Low cognitive function in teens correlates with higher early stroke risk

Following the FDA’s lead, the European Medicines Agency will require labeling for CAR T-cell therapies to include a notice about a risk of second malignancies

Su­per­lu­mi­nal Med­i­cines, a start­up claim­ing that it can use ar­ti­fi­cial in­tel­li­gence to shrink the de­vel­op­ment of pre­clin­i­cal drug can­di­dates from years to a mat­ter of